During the last 30 years, the incidence of oesophagealadenocarcinoma has increased rapidly.
2
Methods: Consecutive patients with oesophagealadenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.
3
Patients with Barrett's oesophagus have an increased risk of developing oesophagealadenocarcinoma and should be kept under surveillance.
4
There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophagealadenocarcinoma.
5
The incidence of oesophagealadenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.
1
Incidence rates for adenocarcinomaoftheesophagus and gastric cardia have been rising rapidly.
2
Methods and materials: Patients with adenocarcinomaoftheesophagus without distant organ metastases were eligible.
3
Incidence increased for several cancers, including pancreas, kidney, and adenocarcinomaoftheesophagus, which are associated with excess weight.
4
Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinomaoftheesophagus were treated.
5
A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinomaoftheesophagus.
Ús de esophageal adenocarcinoma en anglès
1
Barrett's esophagus is an important step in the pathway to esophagealadenocarcinoma.
2
Context: The incidence of esophagealadenocarcinoma is rising and has surpassed squamous cell carcinoma.
3
Future studies of trastuzumab in esophagealadenocarcinoma are indicated.
4
Barrett's esophagus (BE) is the principal risk factor for esophagealadenocarcinoma.
5
Barrett's esophagus is the precursor lesion for esophagealadenocarcinoma.
6
For esophagealadenocarcinoma, work is needed to develop efficient and effective techniques in mass screening programs.
7
Objectives: Alcohol increases esophageal squamous carcinoma risk but has been less consistently associated with esophagealadenocarcinoma.
8
Barrett's esophagus (BE) is the strongest risk factor for the development of esophagealadenocarcinoma.
9
This review outlines the process of pathogenesis of Barrett's metaplasia and its progression to esophagealadenocarcinoma.
10
Background: The National Comprehensive Cancer Network guidelines recommend consideration of surgery for clinical T4a esophagealadenocarcinoma.
11
Objective: The incidence of esophagealadenocarcinoma has risen rapidly in the past two decades, for unknown reasons.
12
Approximately 80% of high-grade dysplasia and esophagealadenocarcinoma cases demonstrated strong to moderate Akt activity.
13
Reflux-induced injury promotes esophagealadenocarcinoma, one of the most rapidly increasing, highly lethal cancers in Western countries.
14
Surgery should be considered for medically fit patients with cT4aN0-3M0 esophagealadenocarcinoma.
15
Our clinical study indicates esophagealadenocarcinoma patients on metformin had a better treatment response than those without metformin.
16
Background: Barrett's esophagus (BE) is known to progress to esophagealadenocarcinoma in a setting of chronic inflammation.